Engineering
(Jan 2024)
Strategy for Viral Safety Risk Reassessment with Changes in the Manufacturing Process of Recombinant Biotechnology Products
- Wenbo Sai,
- Dongchen Jia,
- Hao Chen,
- Wei Wei
Affiliations
- Wenbo Sai
- Center for Drug Evaluation, National Medical Products Administration, Beijing 100076,China
- Dongchen Jia
- Center for Drug Evaluation, National Medical Products Administration, Beijing 100076,China
- Hao Chen
- Center for Drug Evaluation, National Medical Products Administration, Beijing 100076,China
- Wei Wei
- Center for Drug Evaluation, National Medical Products Administration, Beijing 100076,China
- Journal volume & issue
-
Vol. 32
pp.
14
– 17
WeChat QR code